Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Marks

Showing results (511-520 of 683) with videos related to

Pageof 69
Sort By:
American Journal of Hematology|February 24, 2025
Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic LeukemiaMarcos de Lima, Partow Kebriaei, Francesco Lanza, et al.
Annals of Internal Medicine|August 1, 1993
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 yearsD I Marks, J O Cullis, K N Ward, et al.
Future Oncology (London, England)|December 8, 2025
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summaryMarcos de Lima, Partow Kebriaei, Francesco Lanza, et al.
Bone Marrow Transplantation|November 26, 2008
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AMLR K Malladi, A J Peniket, T J Littlewood, et al.
British Journal of Haematology|December 29, 2015
Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and EurocordJohn A Snowden, Robert Danby, Annalisa Ruggeri, et al.
British Journal of Haematology|February 3, 2005
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiationH M Hunter, K Peggs, R Powles, et al.
Bone Marrow Transplantation|January 11, 2000
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantationA J McCarthy, H M Kingman, C Kelly, et al.
Bone Marrow Transplantation|February 4, 2016
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.
Blood|April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesRobert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
The effect of smoking on allogeneic transplant outcomesDavid I Marks, Karen Ballen, Brent R Logan, et al.
Pageof 69

Showing results (511-520 of 683) with videos related to

Sort By:
Pageof 69
American Journal of Hematology|February 24, 2025
Five-Year Real-World Safety of Inotuzumab Ozogamicin Before Hematopoietic Stem Cell Transplantation in B-Cell Precursor Acute Lymphoblastic LeukemiaMarcos de Lima, Partow Kebriaei, Francesco Lanza, et al.
Annals of Internal Medicine|August 1, 1993
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 yearsD I Marks, J O Cullis, K N Ward, et al.
Future Oncology (London, England)|December 8, 2025
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summaryMarcos de Lima, Partow Kebriaei, Francesco Lanza, et al.
Bone Marrow Transplantation|November 26, 2008
Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AMLR K Malladi, A J Peniket, T J Littlewood, et al.
British Journal of Haematology|December 29, 2015
Unrelated Cord Blood Transplantation in adults: evolution, experience and long-term outcomes in the UK National Health Service : a retrospective analysis on behalf of the British Society of Blood and Marrow Transplantation and EurocordJohn A Snowden, Robert Danby, Annalisa Ruggeri, et al.
British Journal of Haematology|February 3, 2005
Analysis of outcome following allogeneic haemopoietic stem cell transplantation for myeloma using myeloablative conditioning--evidence for a superior outcome using melphalan combined with total body irradiationH M Hunter, K Peggs, R Powles, et al.
Bone Marrow Transplantation|January 11, 2000
The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantationA J McCarthy, H M Kingman, C Kelly, et al.
Bone Marrow Transplantation|February 4, 2016
Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysisM L Riches, S Trifilio, M Chen, et al.
Blood|April 6, 2011
Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesRobert J Soiffer, Jennifer Lerademacher, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
The effect of smoking on allogeneic transplant outcomesDavid I Marks, Karen Ballen, Brent R Logan, et al.
Pageof 69